ALNY

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Alnylam Pharmaceuticals Inc

NASDAQ | ALNY

436.38

USD

$0.00

(

0.00%

)

At Close (As of Nov 21, 2025)

$58.90B

Market Cap

1438.03

P/E Ratio

0.31

EPS

$495.55

52 Week High

$205.87

52 Week Low

HEALTHCARE

Sector

ALNY Chart

Recent Chart
Price Action

ALNY Technicals

Tags:

ALNY Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.9B
Total Revenue $2.2B
Cost Of Revenue $323M
Costof Goods And Services Sold $323M
Operating Income -$177M
Selling General And Administrative $976M
Research And Development $1.1B
Operating Expenses $2.1B
Investment Income Net -
Net Interest Income -$20M
Interest Income $122M
Interest Expense $142M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $57M
Income Before Tax -$377M
Income Tax Expense -$99M
Interest And Debt Expense -
Net Income From Continuing Operations -$278M
Comprehensive Income Net Of Tax -
Ebit -$236M
Ebitda -$179M
Net Income -$278M

Revenue & Profitability

Earnings Performance

ALNY Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $4.2B
Total Current Assets $3.3B
Cash And Cash Equivalents At Carrying Value $966M
Cash And Short Term Investments $966M
Inventory $79M
Current Net Receivables $405M
Total Non Current Assets $945M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $1.7B
Other Current Assets $117M
Other Non Current Assets -
Total Liabilities $4.2B
Total Current Liabilities $1.2B
Current Accounts Payable $88M
Deferred Revenue -
Current Debt -
Short Term Debt $155M
Total Non Current Liabilities $3B
Capital Lease Obligations $271M
Long Term Debt $1B
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.7B
Other Current Liabilities $887M
Other Non Current Liabilities $1.7B
Total Shareholder Equity $67M
Treasury Stock -
Retained Earnings -$7.3B
Common Stock $1.3M
Common Stock Shares Outstanding $128M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$8.3M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $57M
Capital Expenditures $34M
Change In Receivables -
Change In Inventory $14M
Profit Loss -
Cashflow From Investment -$117M
Cashflow From Financing $294M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$278M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $1.9B
Total Revenue $2.2B
Cost Of Revenue $323M
Costof Goods And Services Sold $323M
Operating Income -$177M
Selling General And Administrative $976M
Research And Development $1.1B
Operating Expenses $2.1B
Investment Income Net -
Net Interest Income -$20M
Interest Income $122M
Interest Expense $142M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $57M
Income Before Tax -$377M
Income Tax Expense -$99M
Interest And Debt Expense -
Net Income From Continuing Operations -$278M
Comprehensive Income Net Of Tax -
Ebit -$236M
Ebitda -$179M
Net Income -$278M

ALNY News

ALNY Profile

Alnylam Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Alnylam Pharmaceuticals, Inc. is a pioneering biopharmaceutical company headquartered in Cambridge, Massachusetts, specializing in the development and commercialization of transformative RNA interference (RNAi) therapeutics aimed at addressing genetic diseases. The company boasts a robust pipeline of innovative RNAi-based therapies and has made significant strides in the market, including the successful launch of its first commercial product. With a steadfast commitment to scientific excellence and the advancement of medicine, Alnylam is positioned as a leader in the biopharmaceutical sector, striving to redefine treatment paradigms for both rare and prevalent diseases.

LPTX
+368.57%
$2.05
BNKK
+19.70%
$0.17
NVDA
-0.97%
$178.88
IVP
-2.25%
$0.12
NVVE
+55.88%
$0.25
VHAI
-50.00%
$0.00
IVDA
+34.66%
$0.87
DVLT
+46.55%
$2.55
OSRH
+23.37%
$0.56
ONDS
-16.40%
$6.27
PLUG
+4.76%
$1.98
INTC
+2.61%
$34.50
TSLA
-1.04%
$391.09
F
-3.79%
$12.41
SOFI
+1.12%
$25.19
ASST
+3.78%
$1.02
AIIO
+41.76%
$0.78
NWTN
+41.76%
$0.78
BITF
-6.53%
$2.43
BYND
-2.00%
$0.86
GOOGL
+3.52%
$299.66
PFE
+2.62%
$25.04
GRAB
-1.60%
$4.90
CCTG
+43.01%
$0.23
PLTR
-0.57%
$154.85
MNDR
+83.13%
$3.04
AMZN
+1.63%
$220.69
AXDX
-61.36%
$0.03
DNN
-2.37%
$2.26
AMD
-1.08%
$203.78
AAL
+5.14%
$12.87
T
+1.68%
$25.95
ACHR
+4.51%
$7.18
AAPL
+1.96%
$271.49
MARA
-1.66%
$10.07
CIFR
-2.81%
$14.15
NIO
+3.33%
$5.58
BBD
+0.14%
$3.48
BMNR
-0.34%
$25.93
RGTI
+3.46%
$23.59
SOUN
-0.62%
$11.22
ADAP
-15.14%
$0.05
IREN
-2.78%
$42.26
WULF
-2.33%
$11.29
KVUE
+3.15%
$16.66
RIG
-6.34%
$3.84
PCG
-1.07%
$15.67
BAC
+1.09%
$51.56
GOOG
+3.33%
$299.65
WMT
-1.67%
$105.32
NFLX
-1.28%
$104.31
SNAP
-1.15%
$7.69
BTBT
+1.95%
$2.09
QBTS
-0.48%
$20.41
HOOD
+1.02%
$107.30
NOK
+1.53%
$5.96
RMBL
+60.50%
$3.21
SOND
-23.45%
$0.12
LNW
-3.71%
$86.22
CRWV
+3.52%
$71.65
ADD
-25.47%
$0.05
WBD
+1.26%
$23.17
ABEV
+2.26%
$2.48
RIVN
+2.08%
$14.96
NFE
-17.12%
$1.21
ORCL
-5.75%
$198.56
MU
+2.97%
$207.37
IONZ
+28.40%
$6.42
BULL
+0.48%
$8.29
SRM
+53.27%
$10.30
NBIS
-1.63%
$83.26
PLTD
+0.19%
$7.64
UBER
+0.61%
$83.87
RXRX
+8.31%
$4.17
VZ
+1.15%
$41.23
PLTZ
+11.57%
$8.48
BMNU
-1.67%
$5.28
MSFT
-1.31%
$472.12
VALE
-1.65%
$11.92
EOSE
-4.03%
$12.36
APLD
-1.28%
$21.09
BTE
+0.63%
$3.18
CLSK
-4.30%
$9.78
CGC
-3.80%
$1.01
AVGO
-1.90%
$340.20
MSTR
-3.74%
$170.50
IONQ
+1.75%
$41.72
QS
-2.34%
$11.44
TLRY
+0.75%
$0.90
JOBY
+0.23%
$13.07
WLGS
-5.57%
$0.04
BURU
+8.38%
$0.20
SMCI
+1.99%
$32.19
GPUS
-7.53%
$0.20
MTSR
-0.35%
$70.50
CAN
-1.49%
$0.90
VIVK
+12.24%
$0.13
BTG
+0.52%
$3.81
HBAN
+3.62%
$15.87
KO
+2.48%
$72.98
LPTX
+368.57%
$2.05
BNKK
+19.70%
$0.17
NVDA
-0.97%
$178.88
IVP
-2.25%
$0.12
NVVE
+55.88%
$0.25
VHAI
-50.00%
$0.00
IVDA
+34.66%
$0.87
DVLT
+46.55%
$2.55
OSRH
+23.37%
$0.56
ONDS
-16.40%
$6.27
PLUG
+4.76%
$1.98
INTC
+2.61%
$34.50
TSLA
-1.04%
$391.09
F
-3.79%
$12.41
SOFI
+1.12%
$25.19
ASST
+3.78%
$1.02
AIIO
+41.76%
$0.78
NWTN
+41.76%
$0.78
BITF
-6.53%
$2.43
BYND
-2.00%
$0.86
GOOGL
+3.52%
$299.66
PFE
+2.62%
$25.04
GRAB
-1.60%
$4.90
CCTG
+43.01%
$0.23
PLTR
-0.57%
$154.85
MNDR
+83.13%
$3.04
AMZN
+1.63%
$220.69
AXDX
-61.36%
$0.03
DNN
-2.37%
$2.26
AMD
-1.08%
$203.78
AAL
+5.14%
$12.87
T
+1.68%
$25.95
ACHR
+4.51%
$7.18
AAPL
+1.96%
$271.49
MARA
-1.66%
$10.07
CIFR
-2.81%
$14.15
NIO
+3.33%
$5.58
BBD
+0.14%
$3.48
BMNR
-0.34%
$25.93
RGTI
+3.46%
$23.59
SOUN
-0.62%
$11.22
ADAP
-15.14%
$0.05
IREN
-2.78%
$42.26
WULF
-2.33%
$11.29
KVUE
+3.15%
$16.66
RIG
-6.34%
$3.84
PCG
-1.07%
$15.67
BAC
+1.09%
$51.56
GOOG
+3.33%
$299.65
WMT
-1.67%
$105.32
NFLX
-1.28%
$104.31
SNAP
-1.15%
$7.69
BTBT
+1.95%
$2.09
QBTS
-0.48%
$20.41
HOOD
+1.02%
$107.30
NOK
+1.53%
$5.96
RMBL
+60.50%
$3.21
SOND
-23.45%
$0.12
LNW
-3.71%
$86.22
CRWV
+3.52%
$71.65
ADD
-25.47%
$0.05
WBD
+1.26%
$23.17
ABEV
+2.26%
$2.48
RIVN
+2.08%
$14.96
NFE
-17.12%
$1.21
ORCL
-5.75%
$198.56
MU
+2.97%
$207.37
IONZ
+28.40%
$6.42
BULL
+0.48%
$8.29
SRM
+53.27%
$10.30
NBIS
-1.63%
$83.26
PLTD
+0.19%
$7.64
UBER
+0.61%
$83.87
RXRX
+8.31%
$4.17
VZ
+1.15%
$41.23
PLTZ
+11.57%
$8.48
BMNU
-1.67%
$5.28
MSFT
-1.31%
$472.12
VALE
-1.65%
$11.92
EOSE
-4.03%
$12.36
APLD
-1.28%
$21.09
BTE
+0.63%
$3.18
CLSK
-4.30%
$9.78
CGC
-3.80%
$1.01
AVGO
-1.90%
$340.20
MSTR
-3.74%
$170.50
IONQ
+1.75%
$41.72
QS
-2.34%
$11.44
TLRY
+0.75%
$0.90
JOBY
+0.23%
$13.07
WLGS
-5.57%
$0.04
BURU
+8.38%
$0.20
SMCI
+1.99%
$32.19
GPUS
-7.53%
$0.20
MTSR
-0.35%
$70.50
CAN
-1.49%
$0.90
VIVK
+12.24%
$0.13
BTG
+0.52%
$3.81
HBAN
+3.62%
$15.87
KO
+2.48%
$72.98
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.